ArgBP2a, short for Arginine-Rich, Mutated in Early-Stage Tumors Binding Protein 2a, is a key player within the intricate web of cellular signaling networks. This protein is closely associated with the regulation of cytoskeletal organization, which is fundamental to cell shape, motility, and intracellular transport. The expression and activity of ArgBP2a are crucial for maintaining the dynamic balance of cellular architecture and facilitating precise cellular responses to various stimuli. ArgBP2a achieves this by interacting with various partners involved in signal transduction, thereby integrating signals that dictate cell structure and function. It is a scaffold protein, meaning it serves as a physical platform upon which complexes of other proteins can assemble, allowing for efficient and targeted interactions that promote signal amplification and specificity.
The expression of ArgBP2a can be influenced by a diverse array of chemical activators that engage with cellular signaling pathways. Compounds such as Forskolin, known for increasing intracellular cAMP levels, can initiate a cascade of events leading to the activation of protein kinase A (PKA) and subsequent transcriptional events that could include the upregulation of genes like ArgBP2a. Similarly, the application of PMA (Phorbol 12-myristate 13-acetate) is known to activate protein kinase C (PKC), which plays a pivotal role in signal transduction and could lead to changes in gene expression patterns. On the other hand, small molecule inhibitors such as U0126, which targets MEK, could indirectly influence the expression of ArgBP2a by modulating the ERK/MAPK signaling pathway, a route well-documented in its ability to govern gene expression related to cell proliferation and differentiation. Additionally, the use of compounds like Retinoic Acid, which interacts with nuclear receptors, has the potential to alter gene expression profiles, including the stimulation of ArgBP2a transcription. Each chemical activator, through its unique mechanism of action, underscores the complexity of cellular signaling and the fine-tuned regulation of protein expressions such as ArgBP2a.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may upregulate ArgBP2a by elevating intracellular cAMP, which activates PKA, potentially leading to the transcriptional activation of genes including those related to actin cytoskeleton dynamics. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA could stimulate ArgBP2a expression by activating PKC, which may then initiate a signaling cascade resulting in transcriptional changes, including the upregulation of ArgBP2a. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium ions may promote the expression of ArgBP2a through the inhibition of GSK-3β, leading to increased nuclear β-catenin and activation of Wnt target genes, possibly including ArgBP2a. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, could lead to a more open chromatin structure and potentially enhance the transcription of various genes, which may include ArgBP2a. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could induce ArgBP2a expression by causing DNA demethylation, which may lead to the activation of previously silenced genes, including potentially ArgBP2a. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone might promote ArgBP2a expression by activating glucocorticoid receptors, which can stimulate the transcription of target genes, potentially including ArgBP2a. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin could elevate ArgBP2a levels by inducing cellular stress responses, such as the unfolded protein response, which may upregulate specific gene sets including ArgBP2a. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may augment ArgBP2a transcription by activating nuclear receptors that bind to DNA and stimulate the transcription of genes, potentially including ArgBP2a. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB 431542, as an inhibitor of the TGF-β receptor, might indirectly upregulate ArgBP2a by altering the signaling equilibrium within the cell, potentially affecting gene expression patterns. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin might increase ArgBP2a expression by inhibiting mTOR, which could result in a compensatory response in other signaling pathways, leading to gene expression changes. |